In this cohort study of Medicare beneficiaries with incident hypertension, antihypertensive medications that stimulate vs inhibit type 2 and 4 angiotensin II receptors were associated with lower rates of dementia among new users of these medications. Here, SGCG is linked to hypertensive disorder.